Physician profile
Jonathan C Collins
NPI 1053383000
$1,127.79
in general payments reported to CMS, 2019-2025
16 companies · $93.58 in 2025
The $93.58 reported for 2025 was less than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $316 · 2020: $16.42 · 2021: $198 · 2023: $186 · 2024: $318 · 2025: $93.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $597.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $210.25 | 2019-2024 | Jornay Pm |
| Corium, LLC | $200.41 | 2021-2024 | Azstarys |
| Tris Pharma INC | $122.79 | 2019-2024 | Dyanavel Xr |
| Pfizer INC. | $114.92 | 2019-2025 | |
| Supernus Pharmaceuticals, INC. | $114.56 | 2021-2025 | Qelbree, Qelbree |
| Glaxosmithkline, LLC. | $98.78 | 2019-2023 | Bexsero, Pediarix, Rotarix |
| Merck Sharp & Dohme LLC | $50.77 | 2019-2024 | Gardasil 9, Vaxneuvance, Gardasil |
| Ultragenyx Pharmaceutical INC. | $39.10 | 2021 | |
| Genentech USA, INC. | $32.78 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.23 | 2019 | |
| Seqirus USA INC | $29.09 | 2021-2023 | Flucelvax Quadrivalent |
| Celgene Corporation | $21.49 | 2019 | |
| Collegium Pharmaceutical, INC. | $19.47 | 2025 | Jornay Pm |
| Kaleo, INC. | $16.42 | 2020 | |
| Adlon Therapeutics L.P. | $15.53 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $11.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.